Opto | Genome editing

Genome editing

Genome editing is the manipulation of DNA in the genome of a living organism. The theme has shot to prominence in the wake of COVID-19, with the excitement surrounding the potential testing applications of CRISPR technology. ETFs in this space give investors exposure to Bioinformatics, Targeted Therapeutics & Molecular Diagnostics.

Show details

LiveClosed Updated: Refresh

Past performance is not a reliable indicator of future results. All themes

VRTX Stock: Why Did ARK Sell This Biotech?

Industry spotlight
Genomics
Immunology
Biotechnology
Health & wellness

VRTX Stock: Why Did ARK Sell This Biotech?

The Vertex share price has enjoyed a healthy rise this year thanks to its dominance in the cystic fibrosis drug market, although this might come to be challenged. Bringing treatments to the market for other conditions and diseases will likely be key to VRTX stock’s future success.

07 Aug 2024